Pharmaceutical company Lupin Ltd. is bolstering its US branded drugs portfolio with the introduction of Methergine, an oral tablet used to treat postpartum haemorrhage, in the US market.
With the US being Lupin's largest market, the company earned USD 2.06 billion revenue in fiscal year 2015, which garnered 45 percent to the company's annual business.
The company said it has put significant investment in professional education in promoting the drug, which it hoped can be used to handle the rising incidences of maternal deaths that are caused by excessive bleeding.
Lupin ventured into branded specialty products much ahead of its Indian peers with its antibiotic Suprax after securing exclusive rights for the US.
Lupin markets five brands in the US with an aim to strengthen its branded and specialty portfolio through alliances as well as developing its own pipeline and making strategic brand acquisitions.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app